Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.

The Cowboys now face a tough test on Sunday against the defending champions, the Philadelphia Eagles. Jones, who previously ...

Pfizer & Astellas announce US FDA approves Padcev plus Keytruda for certain patients with bladder cancer: New York Monday, November 24, 2025, 12:00 Hrs [IST] Pfizer Inc. and Astel ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...

Rahway, New Jersey Thursday, November 20, 2025, 14:00 Hrs [IST] ...

A new study finds that three existing drugs can force leukemia cells into necroptosis, activating a strong immune response.

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session ...

GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neuronsGT-02287 decreases staining for ...

(Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the appointment of José Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias will lead ...

Amgen announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell ...